Superbugs: antibiotic-resistant microorganisms, a public health problem
DOI:
https://doi.org/10.17140/phoj-11-685Keywords:
superbusgs, multiresistance, antibiotic-resistance mechanismsAbstract
Superbugs are strains of bacteria resistant to several types of antibiotics. Their main characteristic is that they
are capable of mutating their DNA throughout generations to become resistant to the most common drugs,
which is why they represent a serious global health problem that has been contributed by the indiscriminate
use of antibiotics, due to poor administration by the doctor, or by the self-medication to which the population
frequently incurs, is added to this the pharmaceutical industry, the cattle ranch and the agriculture.
Objective: To carry out an updated review on the “superbugs”, causes and mechanisms, and the importance
of the emergence of a policy that regulates the indiscriminate use of antibiotics as well as the social and
environmental factors that favor their emergence.
Material and Methods: A bibliographic search was carried out in different databases on the subject of
microbial resistance and referring to “superbugs”.
Results: Only the most relevant original articles were used with respect to the subject in question, whose
date of publication was lower 10 years ago and from them, the most pertinent information was extracted
regarding the subject that concerns us.
Conclusions: One must think about each and every one of the three causes that are at the origin of the
problem (human, animal and industrial) with respect to the emergence of the “superbugs” since doing
nothing will become one of the worst nightmares of Public Health in the years to come.
References
Organización Mundial de la Salud. La OMS publica la lista de las bacterias para las que se necesitan urgentemente nuevos antibióticos. [Document on the internet]. 2017. [Updated February 12, 2019; cited 12 Feb 19]. Available from: https://www.wh o.int/es/news-room/detail/27-02-2017-w ho-publishes-list-of-bacteria-for-whi ch-new-antibiotics-are-urgently-needed
Esperbent C, Migliorati M. Bacterias multirre-sistentes: Una amenaza oculta que crece. RIA. 2017; 43(1): 6-10.
Cepeda Miinaya D. Amenazas superbacterias, un desafío en alza para la salud. Cinco Días [Doc-ument on the internet]. 2017. [updated Febru-ary 12, 2019; Cited 12 Feb 2019]; Avaliable from: http://www.reigjofre.com/images/desca rgas/esp/noticias/prensa/2017-06-22-C iencia-y-Salud-superbacterias-vs-antib ioticos.pdf
Agencia EFE. La FAO ayuda a seis países latinoamericanos a mitigar bacterias multir-resistentes. [Document on the internet]. 2017. [updated February 10, 2019; Cited 12 Feb 19]. Available from: https://www.efe.com/efe/am erica/sociedad/la-fao-ayuda-a-seis-pai ses-latinoamericanos-mitigar-bacterias -multirresistentes/20000013-3202809
Bonilla A. Superbacterias resistentes a antibióti-cos. [Document on the Internet]. 2018. [Updated February 10, 2019; Cited 12 Feb 2019] Available from: https://www.oei.es/historico/divul gacioncientifica/?Superbacterias-resis tentes-a-antibioticos
Gaze W, Lemaire D. Resistencia a los antimicro-bianos: investigar la dimensión ambiental, ONUN departamento de servicios de publicación, edi-tors. Fronteras, ONU Medio Ambiente; 2017: 16- 22.
González-Andrade F. Superbacterias: la pesadilla del nuevo milenio. [Document on the internet]. 2015. [updated February 12, 2019; cited 12 Febru-ary 2019] Available from: http://www.fabric iogonzalezandrade.com/pdf/infectologia -microbiologia-molecular/2015-superbact erias-la-pesadilla-del-nuevo-milenio.p df
Johnson AP, Woodford N. Global spread of antibi-otic resistance: the example of New Delhi metallo-β-lactamase (NDM)-mediated carbapenem resis-tance. J. Med. Microbiol. 2013;62(4):499-513.
Borrego JJ. Cien años después de la “bala mág-ica”. [Document on the internet]. 2017. [Updated February 10, 2019; cited 12 Feb 2019] Available from: http://www.encuentros.uma.es/asse ts/journals/10/10.162-singles/10.162. 11_article.pdf
Tafur JD, Torres JA, Villegas MV. Mecanismos de resistencia a los antibióticos en bacterias Gram negativas. Infect. 2008;12(3):217-226.
Vignoli R, Seija V. Principales mecanismos de re-sistencia antibiótica. Temas de Bacteriología y vi-rología médica. Dpto. de Bacteriología y Virología, 2da Ed. Corregida, Uruguay: UdelaR, 2006: 649- 662.
Calderón RG. Resistencia antimicrobiana: Mi-croorganismos más resistentes y antibióticos con menor actividad. Rev. Med. Cos. Cen, 2016; 73 (621);757-763.
Moreno MC, González ER, Beltrán C. Mecanismos de resistencia antimicrobiana en patógenos res-piratorios. Rev. Otorrinolaringol. Cir. Cabeza y cuello, 2009; 69(2):185-192.
Kelly BG, Vespermann A, Bolton DJ. Horizon-tal gene transfer of virulence determinants in selected bacterial foodborne pathogens. [Docu-ment on the Internet]. 2009. [Update February 10, 2019; cited 12 Feb 2019] Available from: https: //www.ncbi.nlm.nih.gov/pubmed/18420327
Acevedo Barrios RL, Severiche Sierra CA, Jaimes Morales JC. Antibiotic resistant bacteria in aque-ous ecosystems. Rev. P+L, 2015, 10(2):160-172.
Tzoc E, Arias ML, Valiente C. Efecto de las aguas residuales hospitalarias sobre los patrones de resistencia a antibióticos de Escherichia coli y Aeromonas sp. Rev Biomed, 2004, 15(3):165-172.
Nuñez L, Tornello C, Puentes N, Moreton J. Bac-terias resistentes a antibióticos en aguas grises como agentes de riesgo sanitario. [Document on the internet]. 2012. [Updated February 09, 2019; cited 12 Feb 19] available from: http://www.sc ielo.br/pdf/ambiagua/v7n1/v7n1a18.pdf
Errecalde JO. Uso de antimicrobianos en ani-males de consumo, su incidencia. [Document on the Internet]. 2008. [Updated February 12, 2019; cited 2019 Feb 25] Available from: http://www. fao.org/3/a-y5468s.pdf
Nadal Rocamora I. Uso de lodos de depuradora en agricultura: patógenos y resistencias a antibióti-cos. Rev. Salud Amb. 2015. 15(2): 113-20.
Rovere M. La resistencia antimicrobiana: una per-spectiva internacional e intersectorial. Inmanen-cia. 2017; 6(1):207-14.
França RO, et al. Molecular association of pathogenicity and resistance to multiple an-timicrobials in Acinetobacter baumannii strains recovered from patients with diverse infec-tious diseases. J. Bras Patol. e Med. Lab, 2018; 54(5):288-295.
Simo Tchuinte PL, Rabenandrasana, Kowalewicz C, Andrianoelina V.H, Rakotondrasoa A, Andriani-rina Z.Z. Phenotypic and molecular characteri-sations of carbapenem-resistant Acinetobacter baumannii strains isolated in Madagascar. Microb Pathog, 2019; 8(1): 31.
Reguero MT, et al. Análisis genómico del resis-toma de la cepa de Acinetobacter baumannii. Rev. Colomb. Biotecnol. 2014; 16(2):104–13.
Hong DJ, Bae IK, Jang IH, Jeong SH, Kang HK, Lee K. Epidemiology and characteristics of metallo-β-lactamase-producing Pseudomonas aeruginosa. Rev. Infect. Chemother. 2015; 47(2): 81-97.
Malathi K, Ramaiah S. Mechanism of imipenem resistance in metallo-β-lactamases expressing pathogenic bacterial spp. And identification of potential inhibitors: An in silico approach. J Cell Biochem. 2019; 120(1):584-91.
Chen C-W, Tang H-J, Chen C-C, Lu Y-C, Chen H-J, Su B-A, et al. The Microbiological Characteristics of Carbapenem-Resistant Enterobacteriaceae Car-rying the mcr-1 Gene. J. Clin. Med. 2019; 8(2):261.
Ardite JA. Resistencia a la Vancomicina en el género Enterococus. Rev. Clin Esp. 1995; 195(4): 22-27.
Teglia O. Neisseria gonorrhoeae en la era de la mul-tiresistencia. Rev. Med. Rosario. 2016; 82(1):17– 30.
Gianecini R, Romero M, Vacchino M, Galarza PG. Caracterización molecular de aislamientos de Neisseria gonorrhoeae con susceptibilidad disminuida a cefalosporinas de espectro exten-dido. [Document on the Internet]. 2018. [Updated February 12, 2019; cited 08 April 2019] Available from: https://www.researchgate.net/publi cation/331471936_Genome-based_epidemi ology_and_antimicrobial_resistance_det erminants_of_Neisseria_gonorrhoeae_iso lates_with_decreased_susceptibility_an d_resistance_to_extended-spectrum_ceph alosporins_in_Argentina_in_2
Espinal-Reyes F, Silva-Caso W, Palomares-Reyes C, Levy-Blitchtein S, Bazán-Mayra J, et al. Highly clarithromycin-resistant Helicobacter pylori in-fection in asymptomatic children from a rural community of Cajamarca-Peru. BMC Res. Notes. 2018;11(1):1–6.
Acosta CP, Hurtado FA. Determinación de muta-ciones de un solo nucleótido en el gen 23S rRNA de Helicobacter pylori relacionadas con resisten-cia a claritromicina en una población del departa-mento del Cauca, Colombia. Rev. Biomed. 2014; 34:156–62.
Dalhoff A. Global Fluoroquinolone Resistance Epi-demiology and Implictions for Clinical Use. Inter-discip. Perspect. Infect. Dis. 2012;(3): 37.
Crump JA, Sjölund-Karlsson M, Gordon MA, Parry CM. Epidemiology, Clinical Presentation, Labora-tory Diagnosis, Antimicrobial Resistance, and An-timicrobial Management of Invasive Salmonella Infections. Clin. Microbiol. Rev, 2015; 28: 901-37.
Diawara I, Barguigua A, Katfy K, Nayme K, Be-labbes H, Timinouni M, Zerouali K, Elmdaghri N. Molecular characterization of penicillin non-susceptible Streptococcus pneumoniae isolated before and after pneumococcal conjugate vaccine implementation in Casablanca, Morocco. Clin. Mi-crobiol. Antimicrob. 2017; 16(1):23.
Heinz E. The return of Pfeiffer’s bacillus: Rising incidence of ampicillin resistance in Haemophilus influenzae. Microb Genom. 2018; 4(9): 214.
Superbacterias resistentes a medicamentos matan a 33,000 en Europa. Rev. Forbes de Mex. [Document on the Internet]. 2018. [Updated February 10, 2019; cited 2019 Feb 25]. Available from: https://www.forbes.com.mx/superbac terias-resistentes-a-medicamentos-mat an-a-33000-en-europa
Rubio J. Elsevier talks “La resistencia a los an-timicrobianos está amenazando al control y tratamiento de un gran número de enfermedades en todo el mundo” [Document on the Internet]. 2017. [Updated February 12, 2019; cited 2019 Feb 25]. Available from: https://www.elsevier.c om/es-es/connect/medicina/elseviertal ks-la-resistencia-a-los-antimicrobian os-esta-amenazando-al-control-y-trata miento-de-un-gran-numero-de-enfermeda des-en-todo-el-mundo
Shiva M. Report of a panel discussion “Role of Public Health professionals and the Community in the Control of Antibiotic Resistance”. [Docu-ment on the internet]. 2009. [Updated 13 May 2019; cited 16 Mayo 2019] Available from: http: //cphe.files.wordpress.com/2009/10/ant ibiotic-resistance-sdtt08.pdf
Guzmán F. Ubican patógenos resistentes en agua potable. [Document on the Internet]. 2015. [Up-dated February 12, 2109; cited 2019 Feb 25]. Avail-able from: http://www.gaceta.unam.mx/201 50302/ubican-patogenos-resistentes-e n-agua-potable/
Estrategia Nacional de Acción contra la Resisten-cia a los Antimicrobianos [Internet]. 2023 [cited 2019 Feb 26]. Available from: https://dof.gob. mx/nota_detalle.php?codigo=5525043&fec ha=05/06/2018
Toribio Jiménez Jeiry, Ojendiz Mata Yad Ciri, Orbe Díaz Diana Iveth, López Damián Leonardo, Pérez Salgado Juan, Forero Forero Angela et al. Porta-dores asintomáticos de Staphylococcus aureus meticilino resistentes (MRSA) en pescadores y hor-ticultores de Guerrero, México. JONNPR [Inter-net]. 2020 [citado 2026 Ago 21]; 5(12): 1482-1489. Disponible en: http://scielo.isciii.es/sci elo.php?script=sci_arttext&pid=S2529-8 50X2020001200003&lng=es. Epub 18-Dic-2023. https://dx.doi.org/10.19230/jonnpr.375
Hinojosa Hernández S, Rubio López AN, Sánchez Martínez DV, Flores Chávez OR, Reyes Garnica A, Toribio Jiménez J, López Zermeño MC, Hernández Esparza LC, Cabrera Morales MC, Reynoso Vázquez J, Dimas Ibarra ZA, Ruvalcaba Ledezma JC. STATE OF THE ART REGARDING MONITORING OF THE IN-HOSPITAL ENVIRONMENT AS A STRATEGY TO AVOID THE IMPACT OF “IAAS”. INFECTIONS ASSO-CIATED WITH HEALTH CARE. Capítulo 1, Perspec-tivas integradas en salud, bienestar y calidad de vida 2. Ateneo Editora 2025. Available in: https: //doi.org/10.22533/at.ed.309122508041
Rubio López AN, Hinojosa Hernández S, Raygoza Anaya M, López Zermeño MC, Hernández Esparza LC, Cabrera Morales MC, Reynoso Vázquez J, Flo-res Chávez OR, Ruvalcaba Ledezma JC. MONITOR-ING OF THE HOSPITAL ENVIRONMENT AND COSTS ATTRIBUTABLE TO HEALTH CARE-ASSOCIATED IN-FECTIONS A SYSTEMATIC REVIEW. International Journal Of Health Sciences, 2024; v. 4, n. 35. Avail-able in DOI https://doi.org/10.22533/at.ed .15943524090410
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Public Health - Open Journal (PHOJ) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
